Sanyuan Biological (301206.SZ) released its first-half performance, with a net profit attributable to shareholders of 57.4819 million yuan, representing a 10.73% increase.

Wisdom Financial APP News, Sanyuan Bio (301206.SZ) released its 2025 interim report, with the company's operating income at 3.18 billion yuan, a decrease of 15.62% year-on-year. Net profit attributable to shareholders of listed companies was 574.819 million yuan, an increase of 10.73% year-on-year. Net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 487.566 million yuan, a decrease of 4.70% year-on-year. Basic earnings per share were 0.29 yuan.